7Baggers

Seelos Therapeutics Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20130630 20130930 20131231 20140630 20140930 20141231 20150331 20150630 20150930 20151231 20160331 20160630 20160930 20161231 20190930 20191231 20230331 20230630 20230930 20231231 -17.08-11.98-6.88-1.783.338.4313.5318.63Milllion

Seelos Therapeutics Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2019-12-31 2019-09-30 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2000-09-30 2000-06-30 2000-03-31 1999-06-30 1999-03-31 1998-12-31 1998-09-30 1998-06-30 1998-03-31 1997-12-31 1997-03-31 
  revenue653,000 406,000 336,000 808,000 375,000 375,000 356,000 4,317,000 464,000 626,000 2,629,000 1,273,000 462,000 475,000 1,907,000 1,898,000 5,454,000 362,000 28,000 1,192,000 1,019,000 2,363,173 5,151,713 119,633 781,481 119,488 799,419 1,595,152 1,587,065 862,523 1,193,535 1,470,927 1,445,752 294,835 109,590 102,613 2,466,670 3,500,149 305,943 1,199,612 951,787 403,601 296,390 283,417 286,959 433,057 446,268 533,655 453,947 2,391,949 2,502 2,329 2,381 2,447 63,457 189,266 104,199 43,507 64,552 971 1,713 3,009 78,175 21,563 45,281 390,000 1,100,000 1,220,000 1,750,000 1,530,000 1,210,000 10,000 50,000 
  cost of revenue15,000 14,000 14,000 14,000 74,000 3,491,000 93,000 233,000 38,000 142,000 509,000 233,000 358,000 485,000 75,000 63,000 15,000 702,000 1,918,000 2,688,774 1,705,021 83,845 76,363 90,794 134,718 1,006,225 1,005,008 848,117 1,035,411 1,021,951 1,037,232 128,355 -3 7,965 19,068 -111,229 -41,527 -27,048 370,000 1,040,000 1,150,000 1,610,000 1,380,000 1,040,000 
  gross profit638,000 392,000 322,000 794,000 375,000 375,000 282,000 826,000 371,000 393,000 2,591,000 1,131,000 -47,000 242,000 1,549,000 1,413,000 5,379,000 299,000 13,000 490,000 -899,000 -325,601 3,446,692 35,788 705,118 28,694 664,701 588,927 582,057 14,406 158,124 448,976 408,520 166,480 109,590 102,613 2,466,670 3,500,149 305,943 1,199,612 951,787 403,601 296,390 283,417 286,959 433,057 446,268 533,655 453,947 2,391,949 2,502 2,329 2,381 2,447 63,457 189,266 104,199 43,507 64,552 971 1,713 3,012 78,175 13,598 26,213 111,230 41,528 27,049 20,000 60,000 70,000 140,000 150,000 170,000 10,000 50,000 
  operating expenses                                                                            
  research and development5,918,000 10,022,000 8,509,000 5,668,000 9,198,000 2,641,000 829,000 409,000 2,787,000 2,806,000 3,663,000 4,611,000 3,107,000 3,268,000 15,865,000 1,876,000 2,103,000 1,256,000 919,000 1,535,000 1,413,000 635,912 2,228,822 1,153,811 1,371,922 2,127,059 621,326 1,971,832 1,100,546 692,517 513,920 477,566 426,393 254,650 309,989 716,453 602,366 1,269,546 1,875,474 1,096,402 1,169,091 1,563,281 1,266,792 1,114,715 1,077,883 1,499,310 1,332,351 1,085,501 1,507,975 3,151,515 1,908,623 2,904,560 3,257,401 2,498,350 2,894,407 2,657,372 2,634,348 2,789,949 1,687,459 2,106,598 1,855,334 6,386,442 5,582,531 5,398,227 4,248,587 1,592,716 1,853,062 1,026,396 360,000 320,000 630,000 780,000 500,000 390,000 920,000 290,000 
  sales and marketing-15,000 10,000 10,000 10,000 -10,000 
  general and administrative                                                                            
  total operating expenses2,746,000 2,987,000 2,780,000 4,072,000 1,132,000 1,415,000 1,921,000 1,815,000 2,294,000 2,404,000 2,339,000 2,412,000 2,669,000 3,096,000 2,763,000 2,719,000 2,877,000 3,108,000 2,866,000 3,754,000 3,846,000 2,271,455 3,687,041 2,906,253 3,182,709 2,089,840 2,640,400 2,239,536 1,696,524 714,039 694,749 1,091,047 480,000 480,000 630,000 560,000 730,000 710,000 460,000 280,000 
  operating income8,649,000 13,009,000 10,953,000 8,932,000 10,330,000 3,681,000 2,750,000 2,224,000 5,081,000 5,210,000 6,002,000 7,023,000 5,776,000 6,364,000 18,628,000 4,595,000 4,980,000 4,364,000 3,785,000 5,289,000 5,259,000 3,952,213 6,542,043 4,892,953 5,364,790 4,725,758 2,892,781 8,418,793 4,006,799 14,043,348 2,603,760 3,117,966 2,665,929 1,951,174 1,024,028 1,411,202 1,693,413 3,166,341 3,202,734 2,289,781 2,472,489 3,783,514 2,304,213 2,258,645 2,310,778 3,081,680 2,412,158 2,161,918 -2,886,199 6,067,578 3,137,319 4,328,243 4,567,294 4,739,334 4,695,677 4,234,810 3,994,386 4,922,042 2,912,818 3,414,669 -3,086,954 8,258,785 6,820,793 6,938,240 5,663,316 2,452,442 2,658,206 1,433,594 840,000 800,000 1,260,000 1,350,000 1,240,000 1,100,000 1,390,000 560,000 
  net income-8,010,999 -12,603,000 -10,953,000 -8,932,000 -10,330,000 -3,681,000 -2,482,000 -1,398,000 -4,710,000 -4,817,000 -3,513,000 -5,892,000 -5,823,000 -6,122,000 -17,079,000 -3,182,000 1,245,000 -3,990,000 -3,163,000 -4,053,000 -6,158,000 -12,281,814 -3,095,351 -4,857,165 -4,659,672 -4,697,064 -2,228,080 -7,829,866 -3,424,742 -14,028,942 -2,445,636 -2,668,990 -2,257,409 -2,370,072 -914,438 -1,308,589 773,257 333,808 -2,896,791 -1,090,169 -1,520,702 -3,379,913 -2,007,823 -1,975,228 -2,023,819 -2,648,623 -1,965,890 -1,628,263 3,340,146 -3,675,629 -3,134,817 -4,325,914 -4,564,913 -4,736,887 -4,632,220 -4,045,544 -3,890,187 -4,878,535 -2,848,266 -3,413,698 3,088,667 -8,255,773 -6,742,618 -6,924,642 -5,637,103 -2,341,212 -2,616,678 -1,406,545 -820,000 -740,000 -1,190,000 -1,200,000 -1,080,000 -940,000 -1,380,000 -510,000 

We provide you with 20 years income statements for Seelos Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Seelos Therapeutics stock. Explore the full financial landscape of Seelos Therapeutics stock with our expertly curated income statements.

The information provided in this report about Seelos Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.